Financhill
Sell
46

COCSF Quote, Financials, Valuation and Earnings

Last price:
$9.5500
Seasonality move :
2.04%
Day range:
$9.5500 - $9.5500
52-week range:
$7.0000 - $10.3000
Dividend yield:
3.86%
P/E ratio:
16.67x
P/S ratio:
1.36x
P/B ratio:
2.60x
Volume:
93
Avg. volume:
3.3K
1-year change:
17.03%
Market cap:
$20.1B
Revenue:
$15.3B
EPS (TTM):
$0.57

Earnings Data

Next earnings date for COCSF
Feb 20
2026
Most recent earnings per share
$0.15
Beat by $0.15
(Oct 24/2025)
Consensus Estimate
--
(Oct 24/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

COCSF Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/20/2026 Q4 $4.3B -- -- -- --
10/24/2025 Q3 $3.9B $3.9B $0.15 -- --
07/23/2025 Q2 $3.9B $3.7B $0.13 -- --
04/25/2025 Q1 $3.5B $3.4B $0.12 -- --
02/21/2025 Q4 $3.5B $3.8B $0.17 -- --
10/25/2024 Q3 $3.5B $3.7B $0.15 -- --
07/19/2024 Q2 $3.8B $4B $0.15 -- --
04/24/2024 Q1 $3.6B $3.8B $0.14 -- --
02/22/2024 Q4 $3.9B $3.8B $0.15 -- --
10/25/2023 Q3 $3.5B $3.7B $0.15 -- --
07/25/2023 Q2 -- $3.5B $0.13 -- --
04/27/2023 Q1 -- $3.1B $0.10 -- --
02/23/2023 Q4 -- $3.1B $0.17 -- --
10/24/2022 Q3 -- $2.8B $0.10 -- --
07/25/2022 Q2 -- $2.9B $0.11 -- --
04/28/2022 Q1 -- $2.5B $0.07 -- --
02/24/2022 Q4 -- $2.6B $0.13 -- --
10/27/2021 Q3 -- $2.4B $0.08 -- --
07/26/2021 Q2 -- $2.4B $0.08 -- --
04/26/2021 Q1 -- $2.2B $0.07 -- --
02/25/2021 Q4 -- $2.4B $0.07 -- --
10/26/2020 Q3 -- $2.1B $0.05 -- --
07/22/2020 Q2 -- $1.8B $0.04 -- --
04/29/2020 Q1 -- $2.3B $0.06 -- --
02/26/2020 Q4 -- $2.7B $0.05 -- --
10/25/2019 Q3 -- $2.5B $0.10 -- --
07/25/2019 Q2 -- $2.5B $0.09 -- --
04/26/2019 Q1 -- $2.4B $0.06 -- --
02/26/2019 Q4 -- $2.6B $0.14 -- --
10/25/2018 Q3 -- $2.3B $0.08 -- --
07/26/2018 Q2 -- $2.3B $0.07 -- --
04/25/2018 Q1 -- $2.4B $0.06 -- --
02/22/2018 Q4 -- $2.6B -$0.61 -- --
10/25/2017 Q3 -- $2.5B $0.08 -- --
07/24/2017 Q2 -- $2.7B $0.06 -- --
04/26/2017 Q1 -- $2.5B $0.14 -- --
02/24/2017 Q4 -- $2.5B $0.09 -- --
10/25/2016 Q3 -- $2.3B $0.06 -- --
07/27/2016 Q2 -- $2.2B $0.05 -- --
03/31/2016 Q1 -- $2.1B $0.06 -- --
12/31/2015 Q4 -- $2.4B $0.09 -- --

Coca-Cola FEMSA SAB de CV Earnings Questions

  • How Much did Coca-Cola FEMSA SAB de CV Generate in Revenue Last Quarter?

    Coca-Cola FEMSA SAB de CV reported $3.9B worth of top line sales in its most recent quarter.

  • Did Coca-Cola FEMSA SAB de CV Beat Earnings Last Quarter?

    Coca-Cola FEMSA SAB de CV announced earnings per share of $0.15 which represents a beat of analyst forecast a -- per share.

  • Is Coca-Cola FEMSA SAB de CV Profitable?

    Coca-Cola FEMSA SAB de CV reported $1.7B that represents $0.83 per share over the last quarter.

  • What is the Analyst Consensus for Coca-Cola FEMSA SAB de CV EPS Next Year?

    Coca-Cola FEMSA SAB de CV's earnings are forecast to grow from $0.62 per share to -- per share next year representing an increase of --.

  • When is Coca-Cola FEMSA SAB de CV's Earnings Date?

    Coca-Cola FEMSA SAB de CV's next earnings date is February 20, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock